Hodgkin Lymphoma: Understanding Treatment, Recovery and Your Future Health
Treatment for Hodgkin lymphoma has advanced significantly, offering strong outcomes and a clear path forward for many people. However, the journey to remission raises some important questions: how do treatments actually work and how can you support your own long-term well-being? This one-hour virtual session offers you a clear roadmap to help you understand your care and what to expect, from the first infusion to life without cancer.
In this session, Dr. Michael Crump will explain current treatment approaches in clear, accessible language and share how care continues to support your health beyond active treatment. You’ll gain insight into how therapies work, how your progress is monitored and what this means for your long-term health – helping you feel more informed, confident and empowered as you move forward.
For more resources on Hodgkin lymphoma, visit our dedicated webpage.
Dr. Michael Crump is a hematologist at Princess Margaret Cancer Centre in Toronto, with a clinical and research focus on lymphomas and chronic lymphocytic leukemia. He is Professor of Medicine at the University of Toronto and attending physician in the Division of Medical Oncology and Hematology at the Princess Margaret, University Health Network. He had the very good fortune to be serve as co-chair of Canadian Cancer Trials Group Hematology Committee and Lymphoma Working Group Chair from 2005 to 2018.
Dr. Crump’s current research interests include clinical and translational research in lymphoma, with a focus on development of novel therapies, as well as the late effects of lymphoma treatments. He has been the principal investigator for numerous clinical trials in lymphoma including the two current CCTG trials in Hodgkin lymphoma, HDC.1 and HD.12. and has authored and co-authored more than 200 peer-reviewed publications.
This event was made possible thanks to the support of:
